• All sections
  • C - Chemistrymetallurgy
  • C07D - Heterocyclic compounds
  • C07D 295/108 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by doubly bound oxygen or sulfur atoms with the ring nitrogen atoms and the doubly bound oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Patent holdings for IPC class C07D 295/108

Total number of patents in this class: 104

10-year publication summary

13
10
12
4
10
8
8
3
2
3
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Sarepta Therapeutics, Inc.
382
5
The Cooper Health System
40
4
King Abdulaziz University
512
4
SRI International
1000
4
Sanochemia Pharmazeutika GmbH
37
4
Mitsui Chemicals, Inc.
3230
3
IGM Group B.V.
66
3
PTC Therapeutics, Inc.
484
3
The United States of America, as represented by the Secretary, Department of Health and Human Services
2915
3
FUJIFILM Corporation
29839
2
JSR Corporation
2542
2
Dongguk University Industry-Academic Cooperation Foundation
447
2
Inflectis Bioscience
15
2
Sanochemia Pharmazeutika AG
10
2
Shanghai Institute of Pharmaceutical Industry
128
2
The United States of America,as represented by the Secretary, Department of Health and Human Service
123
2
The United States of America, as Represented by the Secretary, Department of Health and Human Services, Office of Technology Transfer, National Institutes of Health
38
2
Wave Life Sciences Ltd.
181
2
Gotion Inc.
38
2
Huscion Co., Ltd.
10
2
Other owners 49